S. V. T. Sob et al. / Tetrahedron 63 (2007) 8993–8998
8997
Fraction C was treated on a silica gel column chromato-
graphy using n-hexane–EtOAc (95:5) as eluant to yield
coronarin E (72 mg), while fraction D treated in the same
manner gave aulacocarpin A (3.71 g) [n-hexane–EtOAc
100 MHz) data see Table 2. HRCIMS m/z 465.6051
[M+H] (calcd for C H O , 465.6057); CIMS m/z
[M+NH ] 482.
4
+
2
6 41 7
+
(
7:3)] and aulacocarpin B (5.05 g) [n-hexane–EtOAc (6:4)].
3.5. Acid hydrolysis of 2
Some of the compounds were further purified by re-crystalli-
zation in appropriate solvent systems before analyses.
A solution of 2 (0.328 mmol) in a mixture of dioxane (3 ml)
and 1 M HCl (0.66 ml) was stirred at room temperature as
1
7
3
.3.1. Aulacocarpin C (1): 8b(17)-epoxy-14,15,16-trihy-
droxylabd-12-(E)-ene. Brown needles from EtOAc; mp
reported in the litterature. The reaction was monitored
by TLC and found to be completed after 49 h. The reaction
mixture was then neutralized with solid NaHCO , the filtrate
ꢀ
22
D
ꢀ
1
lmax nm (log 3); no absorption above 210. IR (KBr) nmax
60–161 C; [a] +13.71 (c 2.27, CH Cl ); UV (MeOH)
2
2
3
being evaporated. The residue was chromatographed on
silica gel with n-hexane–acetone (95:5) as eluant to give
the furanolabdane 5 (2 mg; 1.9%) as the minor product.
Compounds 6 (44 mg; 44.5%) and 7 (21 mg; 21.2%) were
obtained using n-hexane–acetone (88:12).
3
474 (OH), 1603 (C]C), 1445, 1204, 1093, 1027, 962,
14 and 545 cm ; for H NMR (CD OD, 400 MHz) data
ꢁ
1
1
9
see Table 1. For C NMR (CD OD, 100 MHz) data see Ta-
ble 2. HRCIMS m/z 339.4939 [M+H] (calcd for C H O ,
2
3
3
3
1
3
3
+
0 35 4
+
39.4941); EIMS (70 eV) m/z (rel int.) [MꢁH O] 320 (1),
2
02 (9), 284 (13), 277 (22), 259 (42), 203 (20), 189 (18), 131
3.5.1. Compound 5: 15,16-epoxy-12b-methoxylabda-
8(17)-13(16),14-triene. Colorless oil; H NMR (CDCl ,
1
(
83), 117 (78), 63 (100), 61 (96).
3
1
3
500 MHz) data see Table 1. C NMR (CDCl , 125 MHz)
data see Table 2. HRCIMS m/z 317.4898 [M+H] (calcd
3
+
3.3.2. Aulacocarpin D (2): 15,16-epoxy-14x,16x-di-
methoxylabda-8(17),12-(E)-diene. White needles from
+
for C H O , 317.4905); CIMS m/z [M+NH ] 334.
4
2
1
33
2
ꢀ
22
ꢀ
MeOH; mp 114–115 C; [a]D +36.8 (c 0.38, CH Cl );
2
2
UV (CH Cl ) l nm (log 3) no absorption above 210. IR
max
3.5.2. Compound 6. Compound 6 was isolated as colorless
oil and identified on the basis of its NMR, MS spectra data,
and comparison with previously reported data.
2
2
(
(
KBr) nmax 3454, 1685 (C]C), 1642 (C]C), 1459, 1387
C–O), 1100, 1038, 979, 929, 675 and 578 cm ; for H
ꢁ
1
1
9–11
1
3
NMR (CDCl , 400 MHz) data see Table 1. For C NMR
3
(
[
(
CDCl , 100 MHz) data see Table 2. HRCIMS m/z 349.5321
3
3.5.3. Compound 7. After purification through chromato-
graphy 7 was isolated as colorless needles and identified by
comparison of its NMR data with literature values as being
15,16-epoxy-12b-hydroxylabda-8(17)-13(16),14-triene.
This is the first report of 7 from natural source.
+
M+H] (calcd for C H O , 349.5325); EIMS (70 eV) m/z
2
2 37 3
+
rel int.) [M] 348 (2), 316 (100), 285 (52), 269 (17), 215 (8),
79 (40), 137 (68), 119 (33), 81 (48), 69 (54), 55 (36).
9
–11
1
3
.4. Acetylation of 1
3.6. Biological tests
The triol (1) (0.074 mmol) was shaken in 2 ml of the acetic
anhydride–pyridine (1:1) mixture and allowed to stand at
room temperature for 24 h. The reaction mixture was then
subjected to a 10% HCl solution treatment followed by
a chloroform extraction. The organic phase was further chro-
matographed on an open silica gel column chromatography
using CH Cl –acetone (95:5) to yield the triacetate 1a
The compounds were tested against trypanosome isolates
grown in bloodforms in an HMI-18 medium containing 20%
fetal bovine serum. Coulter counts were made daily and IC50
values determined after 48 h. The strains used in the tests in-
cluded Lab 110 EATRO, KETRI 243, 269, and 243 As 103.
2
2
(
(
24.6 mg; 71.7%) as the major product and compounds 3
5.8 mg; 16.9%) and 4 (3.8 mg; 11.0%), being artefacts
Compound 1 was weakly active against Lab 110 EATRO
(IC50 15.5 mg/ml), KETRI 243 (IC50 29 mg/ml), and KETRI
243 As 103 (IC50 24 mg/ml).
resulting from the opening of the oxonium ion formed by
protonation of the epoxide at C-8 (17) to give the tertiary
carbocation and subsequent elimination of b-protons in the
acidic work-up.
Compound 2 moderately inhibited the growth of the same
pathogenic microbes with IC50 values of 17.5, 21.0, and
24 mg/ml. No activity was shown against KETRI 269.
3
.4.1. Compound 1a: 8b(17)-epoxy-14,15,16-triacetoxy-
labd-12(E)-ene. Syrup; for H NMR (CDCl , 400 MHz)
1
3
1
3
data see Table 1. For C NMR (CDCl , 100 MHz) data
3
see Table 2. HRCIMS m/z 465.6056 [M+H] (calcd for
C H O , 465.6057); CIMS m/z [M+NH ] 482.
Acknowledgements
+
+
The authors are grateful to the International Science Pro-
gram (ISP) (grant No CAM: 02, Uppsala University, Swe-
den.), the Chinese Academy of Sciences (CAS) and the
Third World Academy of Sciences (TWAS) through the
CAS-TWAS fellowship program for their financial support.
2
6
41
7
4
3.4.2. Compound 3: 17-hydroxy-14,15,16-triacetoxy-
labda-8(E),12(Z)-diene. Syrup; for H NMR (CDCl3,
1
1
3
4
1
00 MHz) data see Table 1. For C NMR (CDCl3,
00 MHz) data see Table 2. HRCIMS m/z 465.6047 [M+H]
+
+
(
calcd for C H O , 465.6057); CIMS m/z [M+NH ] 482.
2
6
41
7
4
References and notes
3.4.3. Compound 4: 17-hydroxy-14,15,16-triacetoxy-
labda-7(E),12(Z)-diene. Syrup; for H NMR (CDCl3,
1
1. Badr ꢁe , F. Flore du Cameroun; Mus ꢁe um National de l’Histoire
Naturelle: Paris, 1972.
1
3
4
00 MHz) data see Table 1. For C NMR (CDCl3,